Jincheng Pharm Obtained Tobacco Production License in July 2023
On December 7th, an investor raised a question on an investor interaction platform, inquiring about the amount of nicotine used in e-cigarettes as well as the official data provided by the Tobacco Monopoly Bureau. The investor also sought information regarding the expected date for receiving the official notification.
Jincheng Pharm (300233.SZ) has responded that the company has obtained a new "Tobacco Monopoly Production Enterprise License" in July 2023, as disclosed on the Giant Wave Information Network. The company will organize production and sales in accordance with relevant laws, regulations, and regulatory authorities' requirements.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
